Aug 17, 2022 | Health Care, Health Care Fraud
In June 2022, the U.S. Supreme Court issued an opinion in Ruan v. United States that clarified the mens rea requirement for those who manufacture, distribute, or dispense drugs and are subsequently prosecuted under the Controlled Substances Act, specifically 21 U.S.C....
Aug 9, 2022 | Health Care, Health Care Fraud
The DOJ just announced the conviction of, Jaroslava Ruiz, for her role in a scheme that defrauded private health insurers of approximately $34.6 million. Ruiz, of Chapel Hill, was convicted of one count of conspiracy to commit health care fraud and wire fraud and 10...
Aug 3, 2022 | Health Care, Health Care Fraud
The U.S. Department of Health and Human Services issued a special fraud alert on July 20, 2022, relating to potential fraud concerns in the telehealth industry. Special fraud alerts are rare—this newest alert is only the fourth issued in the last decade. A special...
Aug 3, 2022 | Health Care, Health Care Fraud
The DOJ announced that Paragon Community Healthcare, a Tampa-area pain management clinic, would be closed to resolve allegations of violating the Controlled Substances Act (“CSA”). The clinic owners, Theodore Ferguson II and Timothy Ferguson (the “Fergusons”) along...
Jul 26, 2022 | Health Care, Health Care Fraud
The DOJ announced that father and son pharmacists, Isaac F. Brady III and Isaac F. Brady IV, entered a consent decree to resolve allegations of unlawful opioid distributions. The consent decree restrains and enjoins the pharmacy, Asheboro Drug Company, and its...
Apr 27, 2022 | COVID-19 Related Law, False Claims Act, Fraud Investigations, Government Investigations, Health Care
In May of 2021, the Department of Justice established the COVID-19 Fraud Enforcement Task Force to investigate claims of fraud against COVID-19 relief programs. In March of 2022, the Department announced the appointment of Associate Deputy Attorney General Kevin...
